CM
BIIB icon

Churchill Management’s Biogen BIIB Stock Holding History

Churchill Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,366
Closed -$1.92M – 113
2018
Q4 		$1.92M Sell
6,366
-1,850
-23% -$590K 0.08% 82
2018
Q3 		$2.9M Buy
+8,216
New +$2.83M 0.06% 102
2014
Q4 		– Sell
-126,253
Closed -$41.8M – 175
2014
Q3 		$41.8M Sell
126,253
-18,522
-13% -$6.11M 1.72% 19
2014
Q2 		$45.6M Sell
144,775
-12,541
-8% -$3.77M 2.06% 14
2014
Q1 		$48.1M Buy
157,316
+146,510
+1,356% +$46.5M 1.89% 17
2013
Q4 		$3.02M Buy
+10,806
New +$2.79M 0.12% 67

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Churchill Management's BIIB Position: Q1 2019 in Review

Churchill Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 6,366 shares — an estimated $1.92M sold.

Churchill Management first reported a position in BIIB in Q4 2013 and held it in 6 quarters. The position peaked at $48.1M in Q1 2014. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Churchill Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Churchill Management sold 6,366 Biogen shares in Q1 2019, an estimated $1.92M.
  • Churchill Management first reported a position in Biogen in Q4 2013 and held it in 6 quarters.
  • Churchill Management's Biogen position peaked at $48.1M in Q1 2014.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Churchill Management's 13F filing for Q1 2019, filed 12 Apr 2019.